Researchers discover the Nrf3-mediated mechanism of melanogenesis

NewsGuard 100/100 Score

The skin is presumably the largest and one of the most versatile body organs. By providing a physical barrier, it protects our body from environmental assaults. Melanin-;a natural pigment produced by specialized skin cells called "melanocytes"-;shields our body from the detrimental effects of ultraviolet (UV) radiation. UV radiation is responsible for DNA damage, genetic mutations, and can also lead to the onset of skin cancer. NF-E2-related factor 3 or "Nrf3," a known transcription factor, or protein involved in the process of converting DNA into RNA, is abundantly found in the basal layer of the epidermis. However, its precise role in melanin production remains largely elusive.

Dr. Tsuyoshi Waku and his colleagues from the Laboratory for Genetic Code, the Faculty of Life and Medical Sciences and Graduate School of Life and Medical Sciences, Doshisha University, Japan have recently been able to discover the Nrf3-mediated mechanism of melanogenesis. Using in vitro experimentation, the research team showed that Nrf3 coordinates melanin production by regulating two key processes: macropinocytosis-;engulfment and uptake of large amounts of fluids and membranes-;and autophagy-;recycling of old, damaged, abnormal cell components through controlled cellular breakdown. To this end, the researchers generated mouse malignant melanocyte (melanoma) B16F10 cells overexpressing Nrf3 or depleted the gene in normal human melanocyte (NHEM) cells and conducted a series of well-controlled experiments. This study was made available online on December 30, 2022 and published in volume 32 issue 1 of the journal Cell Reports on January 31, 2023.

Lead author of the study, Dr. Waku, Associate Professor at Doshisha University, muses, "This melanogenic study was started serendipitously. To investigate the effect of Nrf3 on the survival and growth of melanoma cells. We generated melanoma cells stably expressing Nrf3, and found by chance the positive effect of Nrf3 on melanogenesis."

Co-authors, Sota Nakata, Haruka Masuda and Haruna Sumi, students of Doshisha University, discovered that Nrf3 upregulates the gene expression of core melanogenic factors, including Mitf, Tyr, Tyrp1, Pmel, and Oca2, in response to exogenous and endogenous inducers of melanin production, forskolin (Fsk), and αMSH. Moreover, they revealed that Nrf3 also induces the gene expression of Cln3, an autophagosome-related factor, for macropinocytic uptake of melanin precursors. In addition, they identified two autophagy-related genes targeted by Nrf3, i.e., Ulk2 and Gabarapl2, which contribute to the uptake of melanin precursors and the formation of melanosomes-;specialized organelles responsible for the synthesis, storage, and transport of melanin.

Says co-author, Ayaka Wada, a student of Doshisha University, "We showed that Fsk or αMSH induced melanin production in B16F10 or NHEM cells in an Nrf3-dependent manner. Our immunoblotting and immunostaining results suggest that in response to Fsk, Nrf3 translocates from the ER membrane into the nucleus, where it induces melanin production and melanosome formation." Iori Aketa, and Shuuhei Hirose, also students of the university and co-authors of the study, agree.

In fact, the researchers also found that Nrf3 triggers the recycling of skin tissues by facilitating the autolysosomal degradation of melanosomes. Furthermore, the team showed that αMSH-;a hormone that stimulates melanocytes-;causes Nrf3 activation and the subsequent formation of melanin, whereas nelfinavir, an HIV-1 protease inhibitor, inhibits Nrf3-mediated melanin formation.

Dr. Waku enthusiastically adds, "These findings demonstrated the physiological role of Nrf3 in the melanogenesis cascade, via the regulation of cellular membrane dynamics and the core melanogenic gene circuit, as well as the therapeutic potential of nelfinavir in skin hyperpigmentation conditions."

The researchers are hopeful that their novel findings will be of interest not only to other scientists but also to cosmetic and pharmaceutical companies engaged in pigmentation research.

Professor Akira Kobayashi, the principal investigator of the Laboratory for Genetic Code at Doshisha University, concludes, "Our fundamental research purpose is to clarify the tumorigenic effect of Nrf3. This study implies the possibility of the pathophysiological correlation between Nrf3-mediated melanin production and melanoma malignancy."

Melanin functions as a natural sunscreen. However, its excessive production causes melsasma, age spots, and freckles. Although further studies seem warranted, the study does seem to establish a likely association between melanin overproduction and skin cancer.

Source:
Journal reference:

Waku, T., et al. (2022) The CNC-family transcription factor Nrf3 coordinates the melanogenesis cascade through macropinocytosis and autophagy regulation. Cell Reports. doi.org/10.1016/j.celrep.2022.111906.

Comments

  1. Steve Nordquist Steve Nordquist United States says:

    Glow up is expensive! Sounds like nrf3 won't let you be blackish but will let you tan, fade, freckle, age spot and throw a component out there for irregularity as in melanoma. Yayoi Kusama in a cream as melanin precursor, maybe.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis